CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 84 entries

View as:

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients

Phase: N/A Priority: Normal

NCT ID: NCT01718613 Org: User:

Start: 11/30/12 End: 05/31/18 Due: 05/31/19

Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries

Phase: N/A Priority: Normal

NCT ID: NCT02508857 Org: User:

Start: 01/31/10 End: 01/31/14 Due: 01/31/15

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02102438 Org: User:

Start: 04/30/14 End: 04/30/18 Due: 04/30/19

Impact of Surgical Technique on Post-operative Complications in Urgency Ostomy Confection

Phase: N/A Priority: Normal

NCT ID: NCT05635188 Org: User:

Start: 01/31/08 End: 12/31/21 Due: 12/31/22

Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01329627 Org: User:

Start: 08/31/10 End: 08/31/12 Due: 08/31/13

BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]

Phase: N/A Priority: Normal

NCT ID: NCT04510714 Org: User:

Start: 06/01/23 End: 10/01/25 Due: 10/01/26

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02789878 Org: User:

Start: 01/24/19 End: 08/01/22 Due: 08/01/23

Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.

Phase: N/A Priority: Normal

NCT ID: NCT01971034 Org: User:

Start: 06/30/11 End: - Due: -

Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

Phase: N/A Priority: Normal

NCT ID: NCT01329640 Org: User:

Start: 09/30/10 End: 09/30/12 Due: 09/30/13

PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR

Phase: N/A Priority: Normal

NCT ID: NCT02537340 Org: User:

Start: 09/30/16 End: 05/31/19 Due: 05/31/20

Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53

Phase: N/A Priority: Normal

NCT ID: NCT04966923 Org: User:

Start: 12/02/18 End: 02/22/22 Due: 02/22/23

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT04522570 Org: User:

Start: 12/14/20 End: 11/30/26 Due: 11/30/27

Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03213925 Org: User:

Start: 06/01/17 End: 07/01/25 Due: 07/01/26

Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital

Phase: N/A Priority: Normal

NCT ID: NCT04411069 Org: User:

Start: 02/20/19 End: 03/20/21 Due: 03/20/22

Palonosetron Associated to Aprepitant in Prophylaxis of PONV

Phase: N/A Priority: Normal

NCT ID: NCT02431286 Org: User:

Start: 10/31/14 End: 12/31/15 Due: 12/31/16

Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy

Phase: N/A Priority: Normal

NCT ID: NCT02052921 Org: User:

Start: 11/30/11 End: 04/23/20 Due: 04/23/21

Predictive Factors for Postoperative Pain, Nausea and Vomiting in Oncological Patients

Phase: N/A Priority: Normal

NCT ID: NCT04889534 Org: User:

Start: 01/31/15 End: 01/31/17 Due: 01/31/18

Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia

Phase: N/A Priority: Normal

NCT ID: NCT03212456 Org: User:

Start: 01/12/17 End: 12/30/20 Due: 12/30/21

Transfusion Requirements in Critically Ill Oncologic Patient

Phase: N/A Priority: Normal

NCT ID: NCT01648946 Org: User:

Start: 06/30/12 End: 06/30/13 Due: 06/30/14

Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT04350229 Org: User:

Start: 03/27/20 End: 06/20/22 Due: 06/20/23

Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.

Phase: N/A Priority: Normal

NCT ID: NCT01973101 Org: User:

Start: 06/30/12 End: 04/30/17 Due: 04/30/18

Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT03834233 Org: User:

Start: 09/05/19 End: 12/01/22 Due: 12/01/23

Neurolytic Block Techniques In Abdominal Visceral Cancer Pain

Phase: N/A Priority: Normal

NCT ID: NCT06978673 Org: User:

Start: 05/30/25 End: 12/31/26 Due: 12/31/27

Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02064803 Org: User:

Start: 06/30/13 End: 07/31/20 Due: 07/31/21

Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin

Phase: N/A Priority: Normal

NCT ID: NCT05354817 Org: User:

Start: 10/22/21 End: 12/31/23 Due: 12/31/24

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients	NCT01718613	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2012-11-30	2018-05-31	2019-05-31	-	-	2025-07-14
Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries	NCT02508857	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2010-01-31	2014-01-31	2015-01-31	-	-	2025-07-14
Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer	NCT02102438	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2014-04-30	2018-04-30	2019-04-30	-	-	2025-07-14
Impact of Surgical Technique on Post-operative Complications in Urgency Ostomy Confection	NCT05635188	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2008-01-31	2021-12-31	2022-12-31	-	-	2025-07-14
Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer	NCT01329627	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2010-08-31	2012-08-31	2013-08-31	-	-	2025-07-14
BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]	NCT04510714	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2023-06-01	2025-10-01	2026-10-01	-	-	2025-07-14
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer	NCT02789878	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2019-01-24	2022-08-01	2023-08-01	-	-	2025-07-14
Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.	NCT01971034	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2011-06-30	-	-	-	-	2025-07-14
Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)	NCT01329640	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2010-09-30	2012-09-30	2013-09-30	-	-	2025-07-14
PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR	NCT02537340	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2016-09-30	2019-05-31	2020-05-31	-	-	2025-07-14
Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53	NCT04966923	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2018-12-02	2022-02-22	2023-02-22	-	-	2025-07-14
Thermal Ablation of Cervical Metastases From Thyroid Carcinoma	NCT04522570	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2020-12-14	2026-11-30	2027-11-30	-	-	2025-07-14
Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer	NCT03213925	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2017-06-01	2025-07-01	2026-07-01	-	-	2025-07-14
Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital	NCT04411069	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2019-02-20	2021-03-20	2022-03-20	-	-	2025-07-14
Palonosetron Associated to Aprepitant in Prophylaxis of PONV	NCT02431286	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2014-10-31	2015-12-31	2016-12-31	-	-	2025-07-14
Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy	NCT02052921	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2011-11-30	2020-04-23	2021-04-23	-	-	2025-07-14
Predictive Factors for Postoperative Pain, Nausea and Vomiting in Oncological Patients	NCT04889534	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2015-01-31	2017-01-31	2018-01-31	-	-	2025-07-14
Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia	NCT03212456	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2017-01-12	2020-12-30	2021-12-30	-	-	2025-07-14
Transfusion Requirements in Critically Ill Oncologic Patient	NCT01648946	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2012-06-30	2013-06-30	2014-06-30	-	-	2025-07-14
Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer	NCT04350229	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2020-03-27	2022-06-20	2023-06-20	-	-	2025-07-14
Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.	NCT01973101	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2012-06-30	2017-04-30	2018-04-30	-	-	2025-07-14
Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma	NCT03834233	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2019-09-05	2022-12-01	2023-12-01	-	-	2025-07-14
Neurolytic Block Techniques In Abdominal Visceral Cancer Pain	NCT06978673	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2025-05-30	2026-12-31	2027-12-31	-	-	2025-07-14
Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric Cancer	NCT02064803	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2013-06-30	2020-07-31	2021-07-31	-	-	2025-07-14
Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin	NCT05354817	Instituto do Cancer do Estado de São Paulo	user2@example.com	None	2021-10-22	2023-12-31	2024-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance